2D- and 3D-qsar studies of flavonoids, biflavones and chalcones: Antiviral, antibacterial, antifungal, and antimycobacterial activities

Anti-Infective Agents

Volumn 10, Issue 1, 2012, Pages 41-54

  Mercader, Andrew G ^a   Pomilio, Alicia B ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

2D QSAR; 3D QSAR; Antibacterial; Antifungal; Antimycobacterial agents; Antiviral; Biflavonoids; Chalcones; Flavanones; Flavones

Indexed keywords

2 PHENYLCHROMEN 4 ONE; 3 PHENYLCHROMEN 4 ONE; 4 PHENYLCOUMARIN; 5 BROMO 2 HYDROXY 3 [3 (2,3,6 TRICHLOROPHENYL)ACRYLOYL]BENZOIC ACID; 5 BROMO 3 [3 (4 BROMOPHENYL)ACRYLOYL] 2 HYDROXYBENZOIC ACID; 7 O GALLOYTRICETINFLAVAN; 7,4' DI O GALLOYTRICETINFLAVAN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMYCOBACTERIAL AGENT; ANTIVIRUS AGENT; ASTRAGALIN; BETA LACTAM; BETA LACTAMASE INHIBITOR; BMS 707035; CHALCONE DERIVATIVE; ELVITEGRAVIR; FLAVONE DERIVATIVE; FLAVONOID; GINKGETIN; GS 9160; GS 9224; GSK 364735; HINOKIFLAVONE; MK 2048; RALTEGRAVIR; RUTOSIDE; SIALIC ACID; SIALIDASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITEXIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIOSTASIS; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; CORRELATION COEFFICIENT; CYTOPLASM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; IC 50; INFLUENZA; MOLECULAR MODEL; NONHUMAN; PHARMACOPHORE; PROTEIN CONFORMATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTITATIVE STRUCTURE PROPERTY RELATION; VIRUS GENOME; VIRUS REPLICATION;

EID: 84866683690     PISSN: 22113525     EISSN: 22113533     Source Type: Journal    
DOI: 10.2174/2211362611201010041     Document Type: Article

References (63)

1. Tomar, V.; Bhattacharjee, G.; Kamaluddin Kumar, A. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety. Bioorg. Med. Chem. Lett., 2007, 17(19), 5321-5324.
2. Lin, Y.-M.; Zhou, Y.; Flavin, M.T.; Zhou, L.M.; Nie, W.; Chen, F.C. Chalcones and flavonoids as anti-tuberculosis agents. Bioorg. Med. Chem., 2002, 10(8), 2795-2802.
3. Isomoto, H.; Furusu, H.; Ohnita, K.; Wen, C.Y.; Inoue, K.; Kohno, S. Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. World J. Gastroenterol., 2005, 11 (11), 1629-1633.
4. Nowakowska, Z.; Wyrzykiewicz, E.; Kedzia, B. Synthesis and antimicrobial properties of N-substituted derivatives of (E) 4 azachalcones. Il Farmaco 2001, 56(4), 325-329.
5. Freed, E.O. HIV-1 replication. Somat. Cell Mol. Genet.; 2001, 26(1-6), 13-33.
6. Dayam, R.; Deng, J.; Neamati, N. HIV-1 integrase inhibitors: 2003-2004 update. Med. Res. Rev., 2006, 26(3), 271-309.
7. Raghavan, K.; Buolamwini, J.K.; Fesen, M.R.; Pommier, Y.; Kohn, K.W.; Weinstein, J.N. Three-dimensional quantitative structure activity relationship (QSAR) of HIV integrase inhibitors: a com parative molecular field analysis (CoMFA) study. J. Med. Chem., 1995, 38(6), 890-897.
8. Buolamwini, J.K.; Raghavan, K.; Fesen, M.R.; Pommier, Y.; Kohn, K.W.; Weinstein, J.N. Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors. Pharm. Res., 1996, 13(12), 1892-1895.
9. Wang, H.K.; Xia, Y.; Yang, Z.Y.; Natschke, S.L.; Lee, K.H. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. Adv. Exp. Med. Biol., 1998, 439, 191-225.
10. Artico, M.; Di Santo, R.; Costi, R.; Novellino, E.; Greco, G.; Massa, S.; Tramontano, E.; Marongiu, M.E.; De Montis, A.; La Colla, P. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: Synthesis, biological evaluation, and molecular modeling. J. Med. Chem., 1998, 41(21), 3948-3960.
11. Buolamwini, J.K.; Assefa, H. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site. J. Med. Chem., 2002, 45(4), 841-852.
12. Makhija, M.T.; Kulkarni, V.M. QSAR of HIV-1 integrase inhibitors by genetic function approximation method. Bioorg. Med. Chem., 2002, 10(5), 1483-1497.
13. Olivero-Verbel, J.; Pacheco-Londoño, L. Structure-activity relationships for the anti-HIV activity of flavonoids. J. Chem. Inf. Comput. Sci., 2002, 42(5), 1241-1246.
14. Yuan, H.; Parrill, A.L. QSAR studies of HIV-1 integrase inhibition. Bioorg. Med. Chem., 2002, 10(12), 4169-4183.
15. Maurin, C.; Bailly, F.; Cotelle, P. Structure-activity relationships of HIV-1 integrase inhibitors enzyme-ligand interactions. Curr. Med. Chem., 2003, 10(18), 1795-1810.
16. Marrero-Ponce, Y. Linear indices of the molecular pseudograph's atom adjacency matrix: definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors. J. Chem. Inf. Comput. Sci., 2004, 44(6), 2010-2026.
17. Deng, J.; Lee, K.W.; Sanchez, T.; Cui, M.; Neamati, N.; Briggs, J.M. Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. J. Med. Chem., 2005, 48(5), 1496-1505.
18. Lameira, J.; Alves, C.N.; Moliner, V.; Silla, E. A density functional study of flavonoid compounds with anti-HIV activity. Eur. J. Med. Chem., 2006, 41(5), 616-623.
19. Nunthaboot, N.; Tonmunphean, S.; Parasuk, V.; Wolschann, P.; Kokpol, S. Three-dimensional quantitative structure: activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA. Eur. J. Med. Chem., 2006, 41(12), 1359-1372.
20. Veljkovic, V.; Mouscadet, J.F.; Veljkovic, N.; Glisic, S.; Debyser, Z. Simple criterion for selection of flavonoid compounds with antiHIV activity. Bioorg. Med. Chem. Lett., 2007, 17(5), 1226-1232.
21. Iyer, M.; Hopfinger, A.J. Treating chemical diversity in QSAR analysis: modeling diverse HIV-1 integrase inhibitors using 4D fingerprints. J. Chem. Inf. Model., 2007, 47(5), 1945-1960.
22. Saíz-Urra, L.; González, M.P.; Fall, Y.; Gómez, G. Quantitative structure-activity relationship studies of HIV-1 integrase inhibition. 1. GETAWAY descriptors. Eur. J. Med. Chem., 2007, 42(1), 64-70.
23. Al-Mawsawi, L.Q.; Al-Safi, R.I.; Neamati, N. Anti-infectives: clinical progress of HIV-1 IN inhibitors. Expert Opin. Emerg. Drugs, 2008, 13(2): 213-225.
24. Dhaked, D.K.; Verma, J.; Saran, A.; Coutinho, E.C. Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA). J. Mol. Model., 2009, 15(3), 233-245.
25. Sharma, H.; Patil, S.; Sanchez, T.W.; Neamati, N.; Schinazi, R.F.; Buolamwini, J.K. Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors. Bioorg. Med. Chem., 2011, 19(6), 2030-2045.
26. Khedkar, V.M.; Ambre, P.K.; Verma, J.; Shaikh, M.S.; Pissurlenkar, R.R.; Coutinho, E.C. Molecular docking and 3D-QSAR studies of HIV-1 protease inhibitors. J. Mol. Model., 2010, 16(7), 1251-1268.
27. Liu, A.L.; Wang, Y.T.; Du, G.H. Neuraminidase as a target for drugs for the treatment of influenza. Drugs Future, 2005, 30, 799-806.
28. Mercader, A.G.; Pomilio, A.B. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. Eur. J. Med. Chem., 2010, 45(5), 1724-1730.
29. Nowakowska, Z. A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem., 2007, 42(2), 125-137.
30. Hemaiswarya, S.; Kruthiventi, A.K.; Doble, M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine, 2008, 15(8), 639-652.
31. Khobragade, C.N.; Bodade, R.G.; Shinde, M.S.; Jaju, D.R.; Bhosle, R.B.; Dawane, B.S. Microbial and xanthine dehydrogenase inhibitory activity of some flavones. J. Enzyme Inhib. Med. Chem., 2008, 23(3), 341-346.
32. Orhan, D.D.; Özçelik, B.; Özgen, S.; Ergun, F. Antibacterial, antifungal, and antiviral activities of some flavonoids. Microbiol. Res., 2010, 165(6), 496-504.
33. Pappano, N.B.; Puig de Centorbi, O.; Debattista, N.B.; Calleri de Milan, M.C.; Borkowski E.J.; Ferretti, F.H. Cinética de la acción bacteriostática de chalconas naturales y de síntesis sobre una cepa de Staphylococcus aureus. [Kinetics of the bacteriostatic activity of natural and synthetic chalcones on a strain of Staphylococcus aureus]. Rev. Argent. Microbiol., 1985, 17(1), 27-32.
34. Alcaráz, L.E.; Blanco, S.E.; Puig, O.N.; Tomás, F.; Ferretti, F.H. Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains. J. Theor. Biol., 2000, 205(2), 231-240.
35. Sivakumar, P.M.; Priya S.; Doble M. Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents. Chem. Biol. Drug Des., 2009, 73(4), 403-415.
36. Sivakumar, P.M.; Prabhawathi, V.; Doble, M. Antibacterial activity and QSAR of chalcones against biofilm-producing bacteria isolated from marine waters. SAR QSAR Environ. Res., 2010, 21(3-4), 247-263.
37. Wei D.G.; Yang G.F.; Wan J.; Zhan C.G. Binding model construction of antifungal 2-aryl-4-chromanones using CoMFA, CoMSIA, and QSAR analyses. J. Agric. Food Chem., 2005, 53(5), 1604-1611.
38. Sivakumar P.M.; Muthu Kumar T.; Doble M. Antifungal activity, mechanism and QSAR studies on chalcones. Chem Biol Drug Des., 2009, 74(1), 68-79.
39. Pomilio A.B.; Vacchino M.N.; Vitale A.A. Antimycobacterial and antitumoral activities of argentine plants belonging to the Amaranthaceae family. In: South American Medicinal Plants as a Potential Source of Bioactive Compounds. Martino V.S.; Muschietti L.V., Eds.; published by Transworld Research Network, General Manager: NJ Sudarsan, distributed by American Technical Publishers Ltd., Herts, Hitchin, UK, 2008; Chapter 5, pp. 73-113.
40. World Health Organization (WHO). Guidelines for surveillance of drug resistance in tuberculosis. Document WHO/TB/2003.320, Geneva, 2003.
41. World Health Organization (WHO) Interim recommendations for the surveillance of drug resistance in tuberculosis. Document WHO/HTM/TB/2007.385, 1-20, 2007.
42. Lorenti, A.S.; Viale, A.A.; Buschi, C.A.; González, M.D.; Schteingart, C.D.; Iribarren, A.M.; Pomilio, A.B. Antimicrobial activity of some higher plants. Fitoterapia, 1981, 52(2), 81-85.
43. Tomes, C.N.; Viale, A.A.; Buschi, C.A.; Rofi, R.D.; Schteingart, C.D.; Iñigo, R.P.A.; Zallocchi, E.M.; Pomilio, A.B. Antimicrobial screening of some higher plants. Part II. Fitoterapia, 1986, 57(1), 46-50.
44. Pomilio, A.B.; Buschi, C.A.; Tomes, C.N.; Viale A.A. Antimicrobial constituents of Gomphrena martiana and Gomphrena boliviana. J. Ethnopharmacol., 1992, 36(2), 155-161.
45. Buschi, C.A.; Pomilio, A.B.; Gros, E.G. A new flavone from Gomphrena martiana. Phytochemistry, 1979, 18(7), 1249-1250.
46. Buschi, C.A.; Pomilio, A.B.; Gros, E.G. New methylated flavones from Gomphrena martiana. Phytochemistry, 1980, 19(5), 903-906.
47. Buschi, C.A.; Pomilio, A.B.; Gros, E.G. 5,6,7-Trisubstituted flavones from Gomphrena martiana. Phytochemistry, 1981, 20(5), 1178-1180.
48. Buschi, C.A.; Pomilio, A.B. Isorhamnetin 3-O-robinobioside from Gomphrena martiana. J. Nat. Prod., 1982, 45(5), 557-559.
49. Buschi, C.A.; Pomilio, A.B. Terpenoids, flavonoids and protoalkaloids from Gomphrena boliviana. An. Asoc. Quim. Argent., 1982, 70, 855-861.
50. Buschi, C.A.; Pomilio, A.B. Comparative studies on Gomphrena species. An. Asoc. Quim. Argent., 1983, 71, 319-325.
51. Pomilio, A.B.; Buschi, C.A.; Rutty Solá, G.A.; Rumi, L.S. Antitumor screening of Gomphrena species. Fitoterapia, 1991, 62(6), 511-514.
52. Pomilio, A.B.; Rutty Solá, G.A.; Mayer, A.M.; Rumi, L.S. Antitumor and cytotoxic screen of 5,6,7-trisubstituted flavones from Gomphrena martiana. J. Ethnopharmacol., 1994, 44(1), 25-33.
53. Sivakumar, P.M.; Seenivasan, S.P.; Kumar, V.; Doble, M. Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives. Bioorg. Med. Chem. Lett., 2007, 17(6), 1695-700.
54. Sivakumar, P.M.; Geetha Babu, S.K.; Mukesh, D. QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using Genetic Function Approximation (GFA) method. Chem. Pharm. Bull., 2007, 55 (1), 44-49.
55. Sivakumar, P.M.; Kumar, V.; Seenivasan, S.P.; Mohanapriya, J.; Doble, M. Anti-tubercular activity of chalcones Experimental and QSAR studies. In: Advances in Biomedical Research; Anninos, P.; Rossi, M.; Pham, T.D.; Falugi, C.; Bussing, A.; Koukkou, M., Eds.; WSEAS Press, University of Cambridge: Cambridge, UK, 2010; pp. 168-172.
56. Sivakumar, P.M.; Kumar, V; Prabu Seenivasan, S; Mohanapriya, J; Doble, M. Experimental and theoretical approaches to enhance anti tubercular activity of chalcones. WSEAS Trans. Biol. Biomed., 2010, 7(2), 51-61.
57. Hans, R.H.; Guantai, E.M.; Lategan, C.; Smith, P.J.; Wan, B.; Franzblau, S.G.; Gut, J.; Rosenthal, P.J.; Chibale, K. Synthesis, antimalarial and antitubercular activity of acetylenic chalcones. Bioorg. Med. Chem. Lett., 2010, 20(3), 942-944.
58. Mascarello, A.; Chiaradia, L.D.; Vernal, J.; Villarino, A.; Guido, R.V.; Perizzolo, P.; Poirier, V.; Wong, D.; Martins, P.G.; Nunes, R.J.; Yunes, R.A.; Andricopulo, A.D.; Av-Gay, Y.; Terenzi, H. Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth. Bioorg. Med. Chem., 2010, 18(11), 3783-3789.
59. Lin, Y.-M.; Flavin, M.T.; Cassidy, C.S.; Mar, A.; Chen, F.-C. Biflavonoids as novel antituberculosis agents. Bioorg. Med. Chem. Lett., 2001, 11(16), 2101-2104.
60. Dong, Y.Z.; Xu, C.; Zhao, X.L.; Domagala, J.; Drlica, K. Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance. Antimicrob. Agents Chemother., 1998, 42(11), 2978-2984.
61. Zhao, B.Y.; Pine, R.; Domagala, J.; Drlica, K. Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages. Antimicrob. Agents Chemother., 1999, 43(3), 661-666.
62. Karali, N.; Terzio lu, N.; Gürsoy, A. Synthesis and structureactivity relationships of 3-hydrazono-1H-2-indolinones with antituberculosis activity. Arzneim. Forsch., 1998, 48(II), 758-763.
63. Dias, J.C.; Rebelo, M.M.; Alves, C.N. A semi-empirical study of biflavonoid compounds with biological activity against tuberculosis. J. Mol. Struct. (Theochem), 2004, 676(1-3), 83-87.